About the Brokerage Event
The Brokerage Event, held in Brussels on 4-5 November 2025, was designed to facilitate networking and the formation of consortia for IHI’s next single-stage call for proposals, which is scheduled for launch in early 2026.
- Download the event agenda
Presentations
Golden rules for applicants - Hugh Laverty, Head of Scientific Operations, IHI
Pitching session 1 - Pitches with a strong AI and digital component
- Patrick Ryan, Johnson & Johnson - Accelerating Real-world evidence through Continuous Harmonization - ARCH
- Pedro Alves, Promptly Health - AI Factory for Biotech Innovation (AI4BioTech) - Transforming biomedical data into life-saving therapies through AI
- Olalla Aramburu Cabada, Fundació TIC Salut i Social (FTSS) - Advancing Trustworthy AI in Healthcare
- Çiftçi Furkan,TIGA Information Technologies - AIDMED: AI models integrating diverse Data modalities towards advancing MEDical and healthcare domains
- Achraf Tahar, Renal Care & Research - Advanced Digital Twin for Predictive Kidney Health Management
- Steve Thijssen, Wavy Assistant B.V. - ENGAGE2USE: Collaborative Action for Responsive Engagement and Enabling People-Centred Innovation
- Luan Vardari, University “Ukshin Hoti” Prizren - Smart Health Integration in Emerging Regions: AI-Driven Early Diagnostics and Sustainable Care Pathways
- Daniel Weiss, Children's Hospital (LMU Clinic Munich) - AMIGO – The Missing Data-Link: From Sick Children to Precision Care
Pitching session 2 - Pitches with a strong biomarkers component
- Matthias Born, Philips - Oral biomarkers for early detection and monitoring of systemic disease (OBioMar)
- Stephane Commans, IHU ICAN - REACH - Researching the Epidemiology of the Cardiohepatic Axis in Cardiometabolic Health
- Géraldine Farjot, Paris Brain Institute - OneBrain : Redefine boundaries of brain diseases and accelerate therapeutic breakthroughs through large precision brain health cohorts
- Daniel Schobben, Salvia BioElectronics BV - Unravelling mechanism-of-action for improved disease management of disabling neurological conditions including migraine and cluster headache
Pitches with a strong healthcare improvement component
- Christian Muehlendyck, Johnson & Johnson - ELCO-P - Early Lung Cancer Treatment Pathway Optimisation
- Thomas Stacy, Johnson & Johnson - SOCRATES - Surgical Outcomes Classification, Risk Assessment, and Targeted Enhancement System
- Marcin Balcerzyk, Bioaraba Health Research Institute - Dose verification in proton therapy: vivid-pro
- Frauke Christ, KU Leuven & University Hospitals Leuven - Translational platform for Reprogramming Lung Immunity: Enhancing Transplant Survival via Ex Vivo Modulation (TransLUNG)
- Jakob Feldtfos Christensen, DEFACTUM - Mapping People-Centred Integrated Care Pathways Across Europe's Regions (CAREMAP)
- Naomi Nathan, Mobility|Medical goes Additive e.V. (MGA) - BRIDGE-AM: Building Real-world Insights and Digital Generation of Evidence for Additive Manufacturing (AM/(3DPrinting)) in healthcare
- Karel Tesar, Czech Technical University in Prague - Interdisciplinary Consortium for Resorbable Metallic Implants (InCReMI)
Pitches with a strong clinical trials component
- Dariusz Adamczewski, Children’s Tumor Foundation Europe - NF European Drug Discovery and Development Engine
- Daniel Aletaha, Medical University of Vienna - Unifying Europe’s clinical research ecosystem for faster access to innovation
Pitching session 3 - Pitches with a strong imaging component
- Annamaria Csizmadia, GE HealthCare
- Burcu Gumuscu, Philips
- Streamlining Medical imaging Processes with integrated Learning and user-centric innovative Functions for radiology with Artificial Intelligence (Simplif.AI)
- CenTral - Bringing advanced spectral photon counting X-ray technology to hospitals and clinics for equitable access to advanced cancer and stroke diagnostics
- Saverio Gravina, Fondazione Policlinico Universitario Agostino Gemelli IRCCS - ADMIRE: AdvanceD Integrated Medical Imaging and Radiation oncology patient Experience
- Jan-Marc Verlinden, Health Talk BV - NeuroPharm-AI
Pitches with a strong infectious diseases component
- Laurent Lebel, Sanofi - RespiWatch EU
- Graham Somers, GSK -EU Anti-Viral Health Threats
- Gibran Horemheb Rubio Quintanares, Paul Ehrlich Institute
- Jonathan Jones, Centre for Process Innovation (CPI) - Therapeutic and non-therapeutic interventions for addressing anti-microbial resistance (AMR)
- Renate König, Paul-Ehrlich-Institute - VIRAL-INFLAME: from unmasking viral triggers to precision medicine for chronic inflammation
- Katrine Thor Andersen, Allen Institute for Immunology - Decoding Protective Immunity in Global Populations (DECODE)
Other pitches
- Mariam Bayoumi, KUL University-Belgium -Next-Generation Human Niches-on-Chip for Understanding Disease Determinants and Therapeutic Response
- Mark Gontsarik, Centre of Excellence in Sustainable Pharmaceutical Engineering & Manufacturing (CESPE) -Transforming Healthcare: Personalized, Patient-Centred Innovations for All
- Krista Staškevitš, Tartu Applied Health Sciences University - Integrated AI-Powered Remote Management & Patient Empowerment for Hypertension and Diabetes in Primary Care
- Alison Wolfreys, UCB - ISIS: Innovative Solutions to Inform Study Inclusion of Pregnant Women
- Henri Souchay, GE HealthCare - EndoMetriosis: for a Better Recognition, Access and Care Enhancement
Recordings
4 November 2025
5 November 2025